Article
Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling.
European journal of clinical pharmacology - 1 Dec 2009
Jiang Dechun, Bai Xiangrong, Zhang Qingxia, Lu Wei, Wang Yuqin, Li Lin, Müller Markus
Abstract excerpt
PURPOSE: To evaluate the effects of CYP2C19 and CYP2C9 genotypes on the pharmacokinetic variability of valproic acid (VPA) in epileptic patients using a population pharmacokinetic (PPK) approach. METHODS: VPA concentrations were measured in 287 epileptic patients, who were genotyped for CYP2C19*2/*3 and CYP2C9*3. Patients who were on monotherapy with VPA were divided into two groups, a PPK-model group (n = 177)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
